Scandion Oncology: Initial reaction to CORIST phase II interim results - Redeye
Redeye gives its initial impressions about Scandion’s release of positive CORIST phase II interim results. Following the scheduled audiocast at 10 am, we will come back with a more detailed note later today.
ANNONS
Redeye gives its initial impressions about Scandion’s release of positive CORIST phase II interim results. Following the scheduled audiocast at 10 am, we will come back with a more detailed note later today.